China Universal Asset Management Co., Ltd. Castle Biosciences Inc Transaction History
China Universal Asset Management Co., Ltd.
- $1.03 Billion
- Q4 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Castle Biosciences Inc stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 5,939 shares of CSTL stock, worth $157,027. This represents 0.02% of its overall portfolio holdings.
Number of Shares
5,939
Previous 5,335
11.32%
Holding current value
$157,027
Previous $152,000
3.95%
% of portfolio
0.02%
Previous 0.02%
Shares
15 transactions
Others Institutions Holding CSTL
# of Institutions
202Shares Held
24.5MCall Options Held
303KPut Options Held
30.3K-
Black Rock Inc. New York, NY3.04MShares$80.5 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.83MShares$48.3 Million0.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.75MShares$46.2 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.26MShares$33.4 Million0.61% of portfolio
-
Portolan Capital Management, LLC Boston, MA1.26MShares$33.2 Million2.85% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $695M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...